Answers - Legal

The term ‘locking the stable after the horse has bolted’ certainly applies to medical malpra

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ctice suits. Suing a medical practitioner for malpractice can, by definition, only happen af

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

er actual damage has been inflicted. Legally speaking, medical malpractice is a rather vast

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

concept. However, the baseline definition includes areas such as wrongfully administered med

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

cal treatment, damages arising from a doctor’s incompetence, and the resulting loss in terms

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

of wellbeing and finance for the patient.

Derived from the Latin term ‘mala praxis’, medica

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

l malpractice is a legal area that holds the treating doctor responsible for deviating from

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ccepted norms of medical practice by failure to ensure proper treatment parameters. A patien

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

t, while under treatment, is more or less a helpless spectator to the process and has no rea

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

control over it. Loss of health and finance resulting from incompetence or maliciously admi

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

istered wrong treatment therefore puts a high degree of accountability on the treating physi

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

cian. Medical malpractice lawyers specialize in zeroing in on this accountability factor and

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

claiming damages for affected patients.

Malpractice claims depend on the nature of the even

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t in question. Plain negligence on the part of the treating physician, though a serious matt

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

r, would probably not be dealt with as harshly in a court of law as wrongful treatment (via

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

dministration of medicine, surgery or other therapeutic measures). Problems arising out of a

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

physician’s incompetence or ignorance would entail a civil suit, while deliberate malice, i

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

proven, would result in criminal charges against the doctor – and significantly greater res

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

titution in damages for the patient. A good malpractice lawyer will evaluate a client’s clai

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

and attempt to secure the highest amount in damages from the offending medical practitioner

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/130384/answers-Medical-Malpractice-Lawyers.html">Medical Malpractice Lawyers</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/130384/answers-Medical-Malpractice-Lawyers.html]Medical Malpractice Lawyers[/url]

Color drives emotions and emotions are the most important factor in decision-making.

In this 1st article on promotions we will take a look into how to make a successful website.

Nowadays website is one of the better options to promote your business online. The web design company provides help to create an effective web site.

Tags

Links

Answers - Medical Malpractice Lawyers

Related Articles: